ENDRA Life Sciences Stock Price

-0.06 (-9.38%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 116,080
Bid Price 0.58
Ask Price 0.67
News -
Day High 0.67


52 Week Range


Day Low 0.58
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
ENDRA Life Sciences Inc NDRA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.06 -9.38% 0.58 19:20:23
Open Price Low Price High Price Close Price Prev Close
0.67 0.58 0.67 0.60 0.64
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
332 116,080 $ 0.6066297 $ 70,418 - 0.50 - 3.10
Last Trade Time Type Quantity Stock Price Currency
16:33:47 formt 952 $ 0.58 USD


Draw Mode:

ENDRA Life Sciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 24.46M 42.17M 41.21M $ - $ - -0.86 -1.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 2.50%

more financials information »

ENDRA Life Sciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NDRA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.650.680.500.6244866259,943-0.07-10.77%
1 Month0.730.790.500.6895415274,892-0.15-20.55%
3 Months1.501.500.500.897097323,969-0.92-61.33%
6 Months1.842.090.501.30286,304-1.26-68.48%
1 Year2.403.100.502.16793,937-1.82-75.83%
3 Years1.803.500.501.85542,434-1.22-67.78%
5 Years3.9855.880.502.01405,413-3.41-85.45%

ENDRA Life Sciences Description

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI, but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

Your Recent History
ENDRA Life..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.